相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The anti-hepatocellular carcinoma effect of Brucea javanica oil in ascitic tumor-bearing mice: The detection of brusatol and its role
Tongtong Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Acute myeloid leukemia: current progress and future directions
Hagop Kantarjian et al.
BLOOD CANCER JOURNAL (2021)
A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy
Di Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Metabolic Responses to Reductive Stress
Wusheng Xiao et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
CD64-targeted HO-1 RNA interference enhances chemosensitivity in orthotopic model of acute myeloid leukemia and patient-derived bone marrow cells
Seok-Beom Yong et al.
BIOMATERIALS (2020)
FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions
Ahmad I. Antar et al.
LEUKEMIA (2020)
Current Landscape of NRF2 Biomarkers in Clinical Trials
Yoko Yagishita et al.
ANTIOXIDANTS (2020)
FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies
Vanessa E. Kennedy et al.
FRONTIERS IN ONCOLOGY (2020)
Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II
Courtney L. Jones et al.
BLOOD (2019)
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
Jorge E. Cortes et al.
LANCET ONCOLOGY (2019)
Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia
Sankaranarayanan Kannan et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Maintenance therapy in AML: The past, the present and the future
Matteo Molica et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
The Role of Reactive Oxygen Species in Acute Myeloid Leukaemia
Jonathan R. Sillar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
HO-1 promotes resistance to an EZH2 inhibitor through the pRB-E2F pathway: correlation with the progression of myelodysplastic syndrome into acute myeloid leukemia
Zhengchang He et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Targeting FLT3 mutations in AML: review of current knowledge and evidence
Naval Daver et al.
LEUKEMIA (2019)
Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy
Chitra Rajagopal et al.
PHARMACOLOGICAL RESEARCH (2018)
Heme oxygenase inhibition in cancers: possible tools and targets
Paulina Podkalicka et al.
Wspolczesna Onkologia-Contemporary Oncology (2018)
Charting the landscape of genomic instability in acute myeloid leukemia: Interaction between G-quadruplexes and heme oxygenase-1 in leukemia
Anna Konturek-Ciesla et al.
CANCER RESEARCH (2018)
Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine
Yoko Tabe et al.
SCIENTIFIC REPORTS (2018)
Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML
Mohammed Dany et al.
BLOOD (2016)
NOX-driven ROS formation in cell transformation of FLT3-ITD-positive AML
Ashok Kumar Jayavelu et al.
EXPERIMENTAL HEMATOLOGY (2016)
The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance
A. L. Furfaro et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2
Adedamola Olayanju et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
HO-1/CO system in tumor growth, angiogenesis and metabolism Targeting HO-1 as an anti-tumor therapy
Agnieszka Loboda et al.
VASCULAR PHARMACOLOGY (2015)
A NOX2/Egr-1/Fyn pathway delineates new targets for TKI-resistant malignancies
Mary E. Irwin et al.
ONCOTARGET (2015)
The heme oxygenase-1 and c-FLIP in acute myeloid leukemias: two non-redundant but mutually exclusive cellular safeguards protecting cells against TNF-induced cell death?
Oncotarget (2015)
FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanism
Oncotarget (2015)
Redox Control of Leukemia: From Molecular Mechanisms to Therapeutic Opportunities
Mary E. Irwin et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy
Sankaranarayanan Kannan et al.
CARDIOVASCULAR RESEARCH (2013)
Notch activation inhibits AML growth and survival: a potential therapeutic approach
Sankaranarayanan Kannan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Transient Exposure to Quizartinib Mediates Sustained Inhibition of FLT3 Signaling while Specifically Inducing Apoptosis in FLT3-Activated Leukemia Cells
Ruwanthi N. Gunawardane et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Role of Glutathione in Cancer Progression and Chemoresistance
Nicola Traverso et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Dongmei Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Targeting Heme Oxygenase-1 in Vascular Disease
William Durante
CURRENT DRUG TARGETS (2010)
Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction
Kevin J. Pearson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice
Kaeko Hirai et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis
RK Thimmulappa et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Nrf3 negatively regulates antioxidant-response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene
K Sankaranarayanan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor
MC Chillon et al.
HEMATOLOGY JOURNAL (2004)
Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line
JS Armstrong et al.
CELL DEATH AND DIFFERENTIATION (2002)